| 3/22/2024 | 300190200000 | HUMAN URINE (NOT IN THE SCOPE OF 2023/5 COMMUNIQUE ANNEX-1/A) (WILL BE USED IN TREATMENT AND DIAGNOSIS)+ | XXXXXXXXXX | 10 | UNIT | 2812 | GERMANY | NA |
| 3/20/2024 | 300190200000 | HUMAN URINE (NOT IN THE SCOPE OF 2024/5 COMMUNIQUE ANNEX-1/A) (WILL BE USED IN TREATMENT AND DIAGNOSIS)+ | XXXXXXXXXX | 16 | UNIT | 3385 | GERMANY | NA |
| 3/18/2024 | 300190200000 | HUMAN URINE (NOT IN THE SCOPE OF 2024/5 COMMUNIQUE ANNEX-1/A) (WILL BE USED IN TREATMENT AND DIAGNOSIS)+ | XXXXXXXXXX | 222 | UNIT | 19166 | GERMANY | NA |
| 3/11/2024 | 300190200000 | HUMAN URINE (NOT IN THE SCOPE OF 2023/5 COMMUNIQUE ANNEX-1/A) (WILL BE USED IN TREATMENT AND DIAGNOSIS)+ | XXXXXXXXXX | 22 | UNIT | 2665 | GERMANY | NA |
| 3/1/2024 | 300190200000 | HUMAN URINE (NOT IN THE SCOPE OF 2024/5 COMMUNIQUE ANNEX-1/A) (WILL BE USED IN TREATMENT AND DIAGNOSIS)+ | XXXXXXXXXX | 1 | UNIT | 517 | GERMANY | NA |
| 12/19/2023 | 300190200000 | HUMAN URINE (NOT IN THE SCOPE OF 2023/5 COMMUNIQUE ANNEX-1/A) (WILL BE USED IN TREATMENT AND DIAGNOSIS) | XXXXXXXXXX | 10 | UNIT | 520.1 | GERMANY | NA |
| 12/19/2023 | 300190200000 | HUMAN URINE (NOT IN THE SCOPE OF 2023/5 COMMUNIQUE ANNEX-1/A) (WILL BE USED IN TREATMENT AND DIAGNOSIS) | XXXXXXXXXX | 1 | UNIT | 36.43 | GERMANY | NA |
| 12/19/2023 | 300190200000 | HUMAN URINE (NOT IN THE SCOPE OF 2023/5 COMMUNIQUE ANNEX-1/A) (WILL BE USED IN TREATMENT AND DIAGNOSIS) | XXXXXXXXXX | 2 | UNIT | 135.22 | GERMANY | NA |
| 12/19/2023 | 300190200000 | HUMAN URINE (NOT IN THE SCOPE OF 2023/5 COMMUNIQUE ANNEX-1/A) (WILL BE USED IN TREATMENT AND DIAGNOSIS) | XXXXXXXXXX | 5 | UNIT | 396.37 | USA | NA |
| 12/19/2023 | 300190200000 | HUMAN URINE (NOT IN THE SCOPE OF 2023/5 COMMUNIQUE ANNEX-1/A) (WILL BE USED IN TREATMENT AND DIAGNOSIS) | XXXXXXXXXX | 5 | UNIT | 396.37 | USA | NA |